JensonR+

What JensonR+ does

JensonR+ is a UK-based life sciences services firm founded in 2011 and headquartered in Barnstaple, with 11-50 employees. The company provides product development, drug safety (pharmacovigilance), and medical information services to pharmaceutical, biotechnology, and medical device clients. Its service portfolio spans regulatory strategy and operations, quality and compliance, pharmacovigilance and device vigilance, market access and HTA strategy, and due diligence support across product types including pharmaceuticals, biologicals/biosimilars/ATMPs, medical devices and IVDs, combination products, digital health and SaMD, and borderline products.

The firm's delivery backbone is a global regulatory expert network (regulanet®) spanning 90+ countries in North America, LATAM, Europe, MENA, and Asia, which enables cross-border submission support, local regulatory representation, and market entry advisory. Source data attributes a cumulative track record of 2,000+ innovators guided and 10,000+ product submissions across 90 countries since 1994. Current strategic focus areas include digital health and SaMD, AI in regulated life sciences, EU AI Act compliance, and entry into Europe for non-EU sponsors. The firm is led by CEO Sarah Ware and has expanded into adjacent verticals such as food and cosmetics through a sub-brand (nutracompliance.com).

JensonR+ operates as a fee-for-service consultancy, generating revenue through project-based regulatory, development, and market access engagements, supplemented by recurring roles such as EU authorized representative and pharmacovigilance service contracts. Pricing and contract structures are not publicly disclosed. The company's go-to-market emphasizes integrated end-to-end delivery — from development strategy through approval and market access — rather than point-solution consulting.

Name

JensonR+

Website

https://jensonr.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

JensonR+ is a UK-based life sciences services firm providing product development, drug safety, and medical information services to pharmaceutical and medical device clients across regulatory, quality, pharmacovigilance, and market access functions.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Services

NAICS

Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Health Services (8000)

akta.pro primary industry

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

akta.pro secondary industry

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Pharmaceutical regulatory services
• Drug safety services
• Medical information services
• Product development services
• Pharmacovigilance services

Headquarters

HQ city

Barnstaple

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

JensonR+ provides product development, drug safety, and medical information services to life sciences organizations. The firm delivers end-to-end integrated regulatory, clinical, and market access solutions spanning pharmaceuticals, biologics/biosimilars/ATMPs, medical devices and IVDs, combination products, digital health, and SaMD, supported by a global regulatory network.

Product overview

regenold is a global, end-to-end integrated development partner for life sciences companies offering regulatory, development, and market access services. The portfolio consists of regulatory solutions organized by product type (Pharmaceuticals, Biologicals/Biosimilars/ATMPs, Medical Devices & IVDs, Combination Products, Digital Health & SaMD, Borderline Products, Food & Cosmetics), supplemented by service modules covering regulatory strategy, quality/compliance, pharmacovigilance, market access, and due diligence. The company's global reach is enabled through its regulanet® network spanning 90+ countries. The company has guided over 2,000 innovators through development to approval to market access, achieving over 10,000 successful product submissions across 90 countries since 1994.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceuticals Regulatory Solutions

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Full-service CRO with significant regulatory and biopharma services business post-PRA Health Sciences and Symphony Health integration. Provides scaled alternative to boutique regulatory consultancies.
• IQVIA: World's largest CRO/commercial services provider with embedded regulatory, safety, and market access teams. Sets the benchmark against which independent regulatory boutiques are evaluated by enterprise pharma.
• Parexel International: Global full-service CRO with deep regulatory affairs, market access, pharmacovigilance, and clinical development functions. Competes with JensonR+ for regulatory-only RFPs, particularly from mid-cap sponsors.
• Charles River Laboratories: Broader life-sciences services firm with regulatory and safety consulting alongside manufacturing and discovery services. Competes for outsourced development-and-approval engagements from emerging biotech.

Direct peers

• PharmaLex (Cencora PharmaLex): One of the largest pure-play regulatory affairs and pharmacovigilance consultancies for pharma and biotech. Closest comp to JensonR+/regenold on offering breadth, multi-jurisdictional coverage, and lifecycle services across small-molecule and biologic products.
• NAMSA: Specialist medical device and IVD regulatory, quality, and clinical consulting firm — directly comparable to the MDR/IVDR portion of JensonR+'s portfolio, including SaMD and combination product expertise.
• Voisin Consulting Life Sciences (VCLS): Specialist consultancy covering regulatory strategy, clinical development, HTA and market access for pharma, biotech and medtech. Highly comparable mid-sized competitor with multi-region presence and similar ATMP/oncology focus.
• ProPharma Group: Provides regulatory affairs, pharmacovigilance, and quality/compliance consulting to pharma, biologics and medical device manufacturers globally. Direct competitor for outsourced regulatory operations and post-market services.
• DLRC Group: Specialist regulatory consultancy offering regulatory strategy, scientific advice, and global submissions for pharma and biotech. Comparable in size, delivery model and product-type coverage (small molecules through biologics).
• Real Regulatory Ltd: UK-based boutique regulatory affairs consultancy serving pharma and medtech SMEs, with strong MHRA and EMA exposure. Comparable boutique positioning to JensonR+ focused on European submissions and lifecycle support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/jensonr-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JensonR+